Good morning, Broadsheet readers! Hope Solo gets booted from Team USA, Homeland Security is on the Leslie Jones hack, and a chance for you to spend the evening with other Broadsheeters. Have a wonderful weekend.
• All eyes on Bresch. The price hikes of Mylan’s EpiPen—a device commonly used to treat acute allergic reactions—have a lot of fingers pointing at the pharmaceutical’s CEO, Heather Bresch. Many are drawing comparisons between her and Martin Shkreli (a.k.a. the “pharma bro” who was accused of price-gouging earlier this year) because wholesale prices of the EpiPen have risen from less than $100 in 2007 to over $600 today.
Bresch—who was No. 22 on Fortune’s list of Most Powerful Women last year—has had to answer to customers and politicians alike, including Hillary Clinton, who tweeted that “there is no justification” for the hikes and that they are “outrageous.” Bresch defended the higher prices by essentially blaming Obamacare and the U.S. health care system, but later offered the concession of a discount for the drug of up to $300 with the use of a medical coupon card. Mylan stopped short of saying it would lower the wholesale price of the drug.
If you’re interested in getting to know the woman at the center of all this controversy, I highly recommend my colleague Jen Wieczner’s profile of Bresch from September of last year, which is chock-full of details, from her “signature five-inch stilettos” to her “frank-speaking, often chauvinistic” Italian-American family.
ALSO IN THE HEADLINES
• Losing Hope. U.S. Soccer has terminated Hope Solo’s contract and banned the star goalkeeper for six months. The move comes after her inflammatory comments in Rio—she called the Swedish team “cowardly”—but Solo has made missteps before, including alleged involvement in a domestic abuse episode. However, when Fortune‘s Valentina Zarya looked into how other athletes—male athletes—have been treated when they step over the line, it’s not clear that Solo’s punishment fits the crime. Is there a double standard when it comes to the behavior we expect from female athletes?
• Theranos appeals. Blood-testing startup Theranos said yesterday that it plans to appeal a decision made last month by regulators to revoke its license to operate a lab in California, among other penalties. The company’s founder, Elizabeth Holmes, is also banned from the blood-testing business for at least two years.
• Broadsheet bash. Are you in the NYC area? If so, come meet your fellow readers at our first-ever Broadsheet event at Sotheby’s on September 19th at 6pm. I’ll be doing a Q+A and, yes, there will be wine. RSVP at RSVP@Sothebys.com. To check out all the events in our Women of Influence week, click here:
• Justice for Jones. The Department of Homeland Security is now looking into the hack of Leslie Jones’s iCloud. Meanwhile, Fortune’s Ellen McGirt writes that the harassment Jones is experiencing online echoes what many people face in the workplace everyday.
• SAP has no GAP. SAP is the latest tech player to conduct a pay analysis, reporting that 99% of its male and female employees in the U.S. are paid equally. Interestingly, about a third of the 1% who did not have pay parity were male. (The company says it adjusted the pay of all those who were found to be lagging.)
• Burkini boom. The ban on wearing full-body “burkini” bathing suits at French beaches went before the country’s highest administrative court yesterday, with a ruling expected today. Meanwhile, Aheda Zanetti, the woman credited with creating the “burkini,” says that the controversy has boosted her online sales by 200%.
• What do Kobe and HRC have in common? In this week’s Broad Strokes, Valentina Zarya and I talk about what Kobe Bryant’s new VC firm means for women in the industry, whether the attacks on Hillary Clinton’s health are sexist, and why women drop out of engineering.
MOVERS AND SHAKERS: Turner Investments appoints Dr. Stefania A. Perrucci as its global head of fixed income. Prior to joining Turner, Perrucci was the founder of New Sky Capital, where she served as chief investment officer.
IN CASE YOU MISSED IT
• Halt and watch AMC. Are you watching Halt and Catch Fire? Fortune‘s Kia Kokalitcheva, who’s recapping the show, writes about how sexism in Silicon Valley—yep, it was there in 1986 too—is emerging as an important theme this season.
• Passing on the pen. In the wake of the outrage over the pricing of the EpiPen, Sarah Jessica Parker announced that she is ending her arrangement as a spokesperson for Mylan.
• They just do it. Nike’s latest ad spotlights some of my favorite female athletes, including Serena Williams, Simone Biles and Gabby Douglas, amputee triathlete Scout Bassett, and track and field stars Allyson Felix and English Gardner.
• Numbers do lie. The AP is taking some heat for a misleading tweet that read, “More than half those who met Clinton as Cabinet secretary gave money to Clinton Foundation.” In fact, that stat is only accurate if you zero in her meetings with private individuals and don’t count any of the thousands of sit-downs with government officials, dignitaries, etc.
Share today’s Broadsheet with a friend: http://fortune.com/newsletter/broadsheet/
Looking for previous Broadsheets? Click here.
ON MY RADAR
|I think creativity is inside you. If you have something to tell, you expose it. I never went to any design school. I was so strong in my thinking and my way of seeing fashion, I knew exactly what I wanted. I said to myself, 'I have no limits.'|
| -- Iconic fashion designer Sonia Rykiel, who died Thursday in Paris at age 86. |
New York Times